For three decades, Ali Shilatifard, PhD, has dedicated his career to revealing the causes of childhood leukemia and providing detailed molecular insight into the role of epigenetics in cancer. He hopes his discoveries will lead to a super drug that could end childhood leukemia and other cancers.